Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient‐Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient‐Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis

Published:2021-05-12 Issue:7 Volume:5 Page:1201-1211
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Younossi Zobair M.¹²^ORCID,Stepanova Maria³,Noureddin Mazen⁴,Kowdley Kris V.⁵^ORCID,Strasser Simone I.⁶,Kohli Anita⁷,Ruane Peter⁸,Shiffman Mitchell L.⁹,Sheikh Aasim¹⁰,Gunn Nadege¹¹,Caldwell Stephen H.¹²,Huss Ryan S.¹³,Myers Robert P.¹³,Wai‐Sun Wong Vincent¹⁴^ORCID,Alkhouri Naim¹⁵,Goodman Zachary¹²,Loomba Rohit⁴

Affiliation:

1. Betty and Guy Beatty Center for Integrated Research Inova Health System Falls Church VA USA

2. Department of Medicine Center for Liver Diseases Inova Fairfax Hospital Falls Church VA USA

3. Center for Outcomes Research in Liver Disease Washington DC USA

4. NAFLD Research Center University of California at San Diego La Jolla CA USA

5. Liver Institute Northwest Seattle WA USA

6. Royal Prince Alfred Hospital University of Sydney Sydney Australia

7. Arizona Liver Health Chandler AZ USA

8. Ruane Medical and Liver Health Institute Los Angeles CA USA

9. Liver Institute of Virginia Bon Secours Mercy Health Richmond VA USA

10. GI Specialists of Georgia Marietta GA USA

11. Pinnacle Clinical Research Austin TX USA

12. University of Virginia Charlottesville VA USA

13. Gilead Sciences, Inc. Foster City CA USA

14. Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China

15. Texas Liver Institute UT Health San Antonio San Antonio TX USA

Funder

Gilead Sciences

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1710

Reference35 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

3. Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans

4. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

5. Global Prevalence of Nonalcoholic Steatohepatitis (NASH): Findings from a Targeted Literature Review

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH;Health and Quality of Life Outcomes;2023-10-14

2. The Global Burden of Liver Disease;Clinical Gastroenterology and Hepatology;2023-07

3. Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH;Journal of Hepatology;2023-03

4. Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus;PLOS ONE;2023-02-10

5. Editorial: changes of health‐related quality of life associated with hepatic disease severity and its improvement after treatment in NAFLD —authorsʼ reply;Alimentary Pharmacology & Therapeutics;2022-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3